A 3-arm randomised controlled parallel group trial to determine the efficacy of pulmonary rehabilitation in moderate Chronic Obstructive Pulmonary Disease (COPD) patients in primary health care and maintenance of benefits at 2 years

TV3 Marathon Foundation (Fundació La Marató de TV3) (Spain)0 个研究点目标入组 97 人开始时间: 2010年2月11日最近更新: 2015年1月13日

适应症

试验速览

暂无简介。

•1. Clinical diagnosis of COPD with values of forced spirometry after broncodilatation of the ratio Forced Expiration Volume in 1 second (FEV1) / Forced Vital Capacity (FVC) less than 0.7 and FEV1 between 30% and 80% of its reference values (Global Initiative for Chronic Obstructive Lung Disease [GOLD] criteria of moderate COPD).
•2. Age between 35 and 74 years old.
•3. No experience of exacerbation or hospital admission in the month before inclusion.
•4. Willingness to participate in the study and signed informed consent.
•Smoking will not be considered as an exclusion criterion.

•1. Patients with severe and very mild COPD
•2. FEV1<30% and >80%
•3. Relevant osteoarticular disease or other debilitating diseases that could affect normal ambulation
•4. Other important diseases that can impede follow-up (terminal patients, inmunodeficiencies, chronic infections)
•5. Ischaemic heart disease, clinically evident, severe or uncontrolled systemic arterial hypertension.

发起方

TV3 Marathon Foundation (Fundació La Marató de TV3) (Spain)